Completed

ALERT-HFAdherence to Chronic Heart Failure Treatment Guidelines Evaluation

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to observe how well patients with chronic heart failure adhere to their treatment guidelines, specifically looking at the use of ACEI, ARB, beta blockers, loop diuretics, aldosterone antagonists, digoxin, anticoagulant therapy, and implantation of cardiac devices.

What is being collected

Data Collection

Collected at a single point in time - Cross-sectional
Who is being recruted

Over 65 Years
+7 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Case-Only

Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.
Observational
Study Start: November 2012
See protocol details

Summary

Principal SponsorFederico II University
Last updated: March 18, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: November 1, 2012

Actual date on which the first participant was enrolled.

This study, ALERT-HF, focuses on individuals living with chronic heart failure. Its main goal is to assess how well doctors follow current treatment guidelines when caring for these patients. The study also aims to understand the criteria used for diagnosing chronic heart failure. It's important because it can help identify areas for improvement in patient care and ensure that everyone receives the best possible treatment. The study is observational, meaning it involves watching and recording what happens without any direct intervention. During the study, the number of patients receiving specific treatments will be recorded. These treatments include ACEI, ARB, beta blockers, loop diuretics, aldosterone antagonists, digoxin, anticoagulant therapy, and the implantation of cardiac devices. These are all common treatments for chronic heart failure. By tracking how often these treatments are used, the study can provide insights into how closely current treatment guidelines are being followed. The study doesn't involve any new treatments or procedures, it simply observes and records the care that patients are already receiving.

Principal SponsorFederico II University
Last updated: March 18, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

660 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Case-only

These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

3 inclusion criteria required to participate
Age older than 65 years

Diagnosis of Heart Failure

Signature of informed consent

4 exclusion criteria prevent from participating
age less than 65 years

inability to perform periodic checks

indication for cardiac surgery or cardiac surgery by less than 3 months

presence of malignant neoplasms and other severe diseases

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

ARCA Campania healthcare ambulatories

Naples, ItalyOpen ARCA Campania healthcare ambulatories in Google Maps
CompletedOne Study Center